Global DTaP Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 78
Published Date: 20 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global DTaP Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the DTaP Vaccine industry chain, the market status of Government Institution (Inactivated Vaccine, Live Attenuated Vaccine), Private Sector (Inactivated Vaccine, Live Attenuated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of DTaP Vaccine.
Regionally, the report analyzes the DTaP Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global DTaP Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the DTaP Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the DTaP Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Live Attenuated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the DTaP Vaccine market.
Regional Analysis: The report involves examining the DTaP Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the DTaP Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to DTaP Vaccine:
Company Analysis: Report covers individual DTaP Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards DTaP Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Government Institution, Private Sector).
Technology Analysis: Report covers specific technologies relevant to DTaP Vaccine. It assesses the current state, advancements, and potential future developments in DTaP Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the DTaP Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
DTaP Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Market segment by Application
Government Institution
Private Sector
Other
Major players covered
GlaxoSmithKline
Sanofi Pasteur, Ltd.
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTaP Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DTaP Vaccine, with price, sales, revenue and global market share of DTaP Vaccine from 2019 to 2024.
Chapter 3, the DTaP Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTaP Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and DTaP Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of DTaP Vaccine.
Chapter 14 and 15, to describe DTaP Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of DTaP Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DTaP Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Vaccine
1.3.3 Live Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global DTaP Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global DTaP Vaccine Market Size & Forecast
1.5.1 Global DTaP Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global DTaP Vaccine Sales Quantity (2019-2030)
1.5.3 Global DTaP Vaccine Average Price (2019-2030)
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline DTaP Vaccine Product and Services
2.1.4 GlaxoSmithKline DTaP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi Pasteur, Ltd.
2.2.1 Sanofi Pasteur, Ltd. Details
2.2.2 Sanofi Pasteur, Ltd. Major Business
2.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Product and Services
2.2.4 Sanofi Pasteur, Ltd. DTaP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur, Ltd. Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck DTaP Vaccine Product and Services
2.3.4 Merck DTaP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
3.1 Global DTaP Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global DTaP Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global DTaP Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of DTaP Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 DTaP Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 DTaP Vaccine Manufacturer Market Share in 2023
3.5 DTaP Vaccine Market: Overall Company Footprint Analysis
3.5.1 DTaP Vaccine Market: Region Footprint
3.5.2 DTaP Vaccine Market: Company Product Type Footprint
3.5.3 DTaP Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global DTaP Vaccine Market Size by Region
4.1.1 Global DTaP Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global DTaP Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global DTaP Vaccine Average Price by Region (2019-2030)
4.2 North America DTaP Vaccine Consumption Value (2019-2030)
4.3 Europe DTaP Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific DTaP Vaccine Consumption Value (2019-2030)
4.5 South America DTaP Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa DTaP Vaccine Consumption Value (2019-2030)
5.1 Global DTaP Vaccine Sales Quantity by Type (2019-2030)
5.2 Global DTaP Vaccine Consumption Value by Type (2019-2030)
5.3 Global DTaP Vaccine Average Price by Type (2019-2030)
6.1 Global DTaP Vaccine Sales Quantity by Application (2019-2030)
6.2 Global DTaP Vaccine Consumption Value by Application (2019-2030)
6.3 Global DTaP Vaccine Average Price by Application (2019-2030)
7.1 North America DTaP Vaccine Sales Quantity by Type (2019-2030)
7.2 North America DTaP Vaccine Sales Quantity by Application (2019-2030)
7.3 North America DTaP Vaccine Market Size by Country
7.3.1 North America DTaP Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America DTaP Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe DTaP Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe DTaP Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe DTaP Vaccine Market Size by Country
8.3.1 Europe DTaP Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe DTaP Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific DTaP Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific DTaP Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific DTaP Vaccine Market Size by Region
9.3.1 Asia-Pacific DTaP Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific DTaP Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America DTaP Vaccine Sales Quantity by Type (2019-2030)
10.2 South America DTaP Vaccine Sales Quantity by Application (2019-2030)
10.3 South America DTaP Vaccine Market Size by Country
10.3.1 South America DTaP Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America DTaP Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa DTaP Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa DTaP Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa DTaP Vaccine Market Size by Country
11.3.1 Middle East & Africa DTaP Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa DTaP Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 DTaP Vaccine Market Drivers
12.2 DTaP Vaccine Market Restraints
12.3 DTaP Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of DTaP Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of DTaP Vaccine
13.3 DTaP Vaccine Production Process
13.4 DTaP Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DTaP Vaccine Typical Distributors
14.3 DTaP Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global DTaP Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global DTaP Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline DTaP Vaccine Product and Services
Table 6. GlaxoSmithKline DTaP Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Pasteur, Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur, Ltd. Major Business
Table 10. Sanofi Pasteur, Ltd. DTaP Vaccine Product and Services
Table 11. Sanofi Pasteur, Ltd. DTaP Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur, Ltd. Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck DTaP Vaccine Product and Services
Table 16. Merck DTaP Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Global DTaP Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 19. Global DTaP Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 20. Global DTaP Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 21. Market Position of Manufacturers in DTaP Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 22. Head Office and DTaP Vaccine Production Site of Key Manufacturer
Table 23. DTaP Vaccine Market: Company Product Type Footprint
Table 24. DTaP Vaccine Market: Company Product Application Footprint
Table 25. DTaP Vaccine New Market Entrants and Barriers to Market Entry
Table 26. DTaP Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global DTaP Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 28. Global DTaP Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 29. Global DTaP Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 30. Global DTaP Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 31. Global DTaP Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 32. Global DTaP Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 33. Global DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 34. Global DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 35. Global DTaP Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Global DTaP Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Global DTaP Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 38. Global DTaP Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 39. Global DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 40. Global DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 41. Global DTaP Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 42. Global DTaP Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 43. Global DTaP Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 44. Global DTaP Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 45. North America DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 46. North America DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 47. North America DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 48. North America DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 49. North America DTaP Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 50. North America DTaP Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 51. North America DTaP Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 52. North America DTaP Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Europe DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 54. Europe DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 55. Europe DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 56. Europe DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 57. Europe DTaP Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 58. Europe DTaP Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 59. Europe DTaP Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe DTaP Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 62. Asia-Pacific DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 63. Asia-Pacific DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 64. Asia-Pacific DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 65. Asia-Pacific DTaP Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 66. Asia-Pacific DTaP Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 67. Asia-Pacific DTaP Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 68. Asia-Pacific DTaP Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 69. South America DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 70. South America DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 71. South America DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 72. South America DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 73. South America DTaP Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 74. South America DTaP Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 75. South America DTaP Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America DTaP Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa DTaP Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 78. Middle East & Africa DTaP Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 79. Middle East & Africa DTaP Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 80. Middle East & Africa DTaP Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 81. Middle East & Africa DTaP Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 82. Middle East & Africa DTaP Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 83. Middle East & Africa DTaP Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 84. Middle East & Africa DTaP Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 85. DTaP Vaccine Raw Material
Table 86. Key Manufacturers of DTaP Vaccine Raw Materials
Table 87. DTaP Vaccine Typical Distributors
Table 88. DTaP Vaccine Typical Customers
List of Figures
Figure 1. DTaP Vaccine Picture
Figure 2. Global DTaP Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global DTaP Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Vaccine Examples
Figure 5. Live Attenuated Vaccine Examples
Figure 6. Global DTaP Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global DTaP Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Government Institution Examples
Figure 9. Private Sector Examples
Figure 10. Other Examples
Figure 11. Global DTaP Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global DTaP Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global DTaP Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 14. Global DTaP Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 15. Global DTaP Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global DTaP Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of DTaP Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 DTaP Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 DTaP Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global DTaP Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global DTaP Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America DTaP Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe DTaP Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific DTaP Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America DTaP Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa DTaP Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global DTaP Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global DTaP Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 30. Global DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global DTaP Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 32. Global DTaP Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 33. North America DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America DTaP Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America DTaP Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe DTaP Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe DTaP Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific DTaP Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific DTaP Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America DTaP Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America DTaP Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa DTaP Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa DTaP Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa DTaP Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa DTaP Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa DTaP Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. DTaP Vaccine Market Drivers
Figure 74. DTaP Vaccine Market Restraints
Figure 75. DTaP Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of DTaP Vaccine in 2023
Figure 78. Manufacturing Process Analysis of DTaP Vaccine
Figure 79. DTaP Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GlaxoSmithKline Sanofi Pasteur, Ltd. Merck
Related Reports
03 Mar 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
